Patient perspectives of allergic rhinitis and allergen immunotherapy: A qualitative study
Sufferers of AR experience an impactful symptom journey, with many achieving inadequate disease control despite symptomatic pharmacotherapy. The uptake of AIT is constrained by direct medication costs, insufficient public awareness, and limited prescriber availability. The findings of this study offer insights for health care professionals and policymakers to formulate strategies to enhance AR management and improve AIT access for eligible patients.
Authors
- Adrian J. Lowe (ORCID: https://orcid.org/0000-0002-4691-8162)
- Constance H. Katelaris (ORCID: https://orcid.org/0000-0002-4412-1336)
- Melanie Lloyd (ORCID: https://orcid.org/0000-0002-3889-5458)
- Joshua Jacob (ORCID: https://orcid.org/0000-0002-1112-2033)
- Chris Joyce (ORCID: https://orcid.org/0000-0001-7819-3373)
Institutions
- Camden and Campbelltown Hospitals (AU)
- The University of Melbourne (AU)
- National Institute of Allergy and Infectious Diseases (US)
- Murdoch Children's Research Institute (AU)
- Monash University (AU)
- Western Sydney University (AU)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.jacig.2025.100621
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00